Advertisement
Screener

BRUKER CORPORATION (BRKR) Overview

BRUKER CORPORATION (BRKR) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.41; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.02; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.41; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 0.05; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$31.12$36.38$42.52$49.71$58.10$67.922025-11-062026-11-06$27.88$35.98$46.42$59.89$77.27$99.702021-11-082026-11-06$20.03$27.72$38.38$53.13$73.56$101.832016-11-072026-11-06$3.18$6.37$12.75$25.53$51.12$102.332006-11-062026-11-06$2.47$5.20$10.96$23.07$48.59$102.332000-08-042026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$61.31
Previous close
$64.51
Change
-$3.20
Change (%)
-4.96%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

BRKR
+37.18%
S&P 500
(m)

1 year

BRKR
+109.47%
S&P 500
(m)

3 years

BRKR
+4.64%
S&P 500
(m)

5 years

BRKR
-17.07%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.41

-0.49-0.29-0.100.090.2931 Mar 2025: estimate (m); actual 0.1131 Mar 2025(m)30 Jun 2025: estimate (m); actual 0.0530 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.4130 Sept 2025(m)31 Mar 2026: estimate (m); actual 0.0231 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.4130 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.41(m)(m)
1 Jan 202631 Mar 2026(m)0.02(m)(m)
1 Jul 202530 Sept 2025(m)-0.41(m)(m)
1 Apr 202530 Jun 2025(m)0.05(m)(m)
1 Jan 202531 Mar 2025(m)0.11(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -0.15

-0.230.601.432.253.0831 Dec 2021: estimate (m); actual 1.8131 Dec 2021(m)31 Dec 2022: estimate (m); actual 1.9931 Dec 2022(m)31 Dec 2023: estimate (m); actual 2.9031 Dec 2023(m)31 Dec 2024: estimate (m); actual 0.7631 Dec 2024(m)31 Dec 2025: estimate (m); actual -0.1531 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-0.15(m)(m)
1 Jan 202431 Dec 2024(m)0.76(m)(m)
1 Jan 202331 Dec 2023(m)2.90(m)(m)
1 Jan 202231 Dec 2022(m)1.99(m)(m)
1 Jan 202131 Dec 2021(m)1.81(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 838.50M ■ Earnings -52.00M — Profit margin -6.20%

-184.02M-7.9%244.53M-4.1%673.07M-0.2%1101.62M3.7%30 Sept 2025: revenue 860.50M; earnings -59.60M; profit margin -6.93%30 Sept 202531 Dec 2025: revenue 977.20M*; earnings 26.30M*; profit margin 2.69%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 823.40M; earnings 14.40M; profit margin 1.75%31 Mar 202630 Jun 2026: revenue 838.50M; earnings -52.00M; profit margin -6.20%30 Jun 2026

31 Dec 2025 ■ Revenue 3.44B ■ Earnings -0.01B — Profit margin -0.24%

-0.42B-1.2%1.00B4.3%2.43B9.9%3.85B15.5%31 Dec 2022: revenue 2.53B; earnings 0.30B; profit margin 11.80%31 Dec 202231 Dec 2023: revenue 2.96B; earnings 0.43B; profit margin 14.45%31 Dec 202331 Dec 2024: revenue 3.37B; earnings 0.11B; profit margin 3.38%31 Dec 202431 Dec 2025: revenue 3.44B; earnings -0.01B; profit margin -0.24%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$61.31(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$61.31High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning BRKR

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
2.27M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
5.36%*
Total return · month
13.00%*
Total return · quarter
7.98%*
Total return · half year
91.36%*
Total return · year to date
37.18%*
Total return · 1 year
109.47%*
Total return · 3 years
4.64%*
Total return · 5 years
-17.07%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

BRUKER CORPORATION Overview

View more →

(m)

(m)

SEC CIK
1109354
Industry (SIC)
3826 Laboratory Analytical Instruments
Country of operation
United States
Business address
40 MANNING RD, BILLERICA, Massachusetts, 01821, United States
Fiscal year end
1231
Phone
978663-3660

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
REVVITY, INC. (RVTY)United States$16.814B53.44
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34